AMPAC Fine Chemicals and Codexis Enter Into a Manufacturing Partnership

01-Apr-2010 - AMPAC Fine Chemicals LLC (AFC), a subsidiary of American Pacific Corporation announced that it has entered into a manufacturing partnership with Codexis, Inc. Under a new agreement, AFC will partner with Codexis to use Codexis' proprietary biocatalysis technology in combination with AFC's ...

Sigma-Aldrich Acquires Iropharm to Expand cGMP Capacity

05-May-2006 - Sigma-Aldrich Corporation announced that it has acquired Honeywell International's Iropharm unit, a custom chemical synthesis business located in Arklow, Ireland. The addition of Iropharm will substantially increase SAFC's active pharmaceutical ingredient (API) and pharmaceutical intermediates ...

Degussa and Hikal sign manufacturing agreement

16-Mar-2006 - The Exclusive Synthesis & Catalysts business unit of Degussa AG, Dusseldorf, Germany, has announced that it has signed a long-term, non-exclusive agreement with Hikal Ltd., India, for a cooperation on the manufacture of pharmaceutical intermediates and APIs. Under this agreement Degussa will ...

Rockwood Specialties Completes Acquisition of Four Dynamit Nobel Businesses To Form New Global Specialty Chemical Group

09-Aug-2004 - Specialties Group, Inc., Princeton (NJ), announced today that it has completed the acquisition of four businesses of Dynamit Nobel, Troisdorf (Germany), to form a new specialty chemicals and advanced materials group with pro forma combined revenue of approximately $2.5 billion in 2003. To create ...

Diversa Licenses Enzyme for Chiral Intermediate to BASF

02-Dec-2003 - Diversa Corporation has licensed a proprietary enzyme for the biocatalytic synthesis of a pharmaceutical intermediate to BASF. BASF will produce the biocatalyst and apply it in one of their proprietary biocatalytic processes to synthesize a chiral intermediate. This is the first product licensed ...

Degussa Fine Chemicals Strengthens Activities in China

Construction of New Plant for the Production of Pharmaceutical grade L-Methionine in Wuming

21-Jan-2003 - In January 2003, the Degussa Fine Chemicals Business Unit of Degussa AG, Dusseldorf, Germany, began construction of a new plant for the pharmaceutical amino acid L-methionine in Wuming, in southern China. Planned to start in the first quarter of 2004, the plant will have an annual capacity of ...

Focus on bonding and surfacing: Dynea divests Krems Chemie Chemicals Services GmbH

06-Mar-2002 - March 5, 2002 Dynea Oy, the parent company of Dynea International Oy, has sold the entire share capital in Krems Chemie Chemicals Services GmbH, a custom manufacturing business located in Krems, Austria, to Gerald Moser GmbH and Co KG. The transaction was closed on March 4, 2002. KCCS GmbH ...

DSM Venturing invests in NextGen Enabling Technologies Fund

18-Jan-2002 - DSM has invested USD 3 million in the NextGen Enabling Technologies Fund. This is a Venture Capital Fund (VCF) located in Santa Barbara (California, USA) which is focusing on investments in early stage companies in the area of High Performance Materials for use in for example electronics, optics, ...

Dow and Diversa Advance Enzyme Candidates for Production of Pharmaceutical Intermediates

21-Nov-2001 - Midland, Michigan and San Diego, California - November 19, 2001 - The Dow Chemical Company (NYSE: Dow) and Diversa Corporation (Nasdaq: DVSA) announced they have expanded their agreement to identify biocatalytic processes to replace traditional and costly multi-step chemical synthesis. The ...

Synetix Completes Acquisition of Catalyst Business

22-Jan-2001 - ICI Synetix has completed the acquisition of the 'CelActiv' catalyst business from the German manufacturer, Celanese Chemicals Europe GmbH, including the manufacturing assets also associated with the 'Hoecat' catalystSynetix is a global business with around 5,000 customers in over 85 countries. ...